BioLargo, Inc. (NASDAQ:BLGO - Get Free Report)'s stock price fell 1.3% during mid-day trading on Wednesday . The company traded as low as $0.20 and last traded at $0.20. 491,702 shares traded hands during trading, an increase of 64% from the average session volume of 300,335 shares. The stock had previously closed at $0.20.
BioLargo Stock Performance
The company has a quick ratio of 2.24, a current ratio of 2.31 and a debt-to-equity ratio of 0.03. The firm has a market capitalization of $61.22 million, a P/E ratio of -20.00 and a beta of 0.11. The stock has a fifty day moving average of $0.21 and a 200-day moving average of $0.24.
About BioLargo
(
Get Free Report)
BioLargo, Inc invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider BioLargo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioLargo wasn't on the list.
While BioLargo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
